About Axxelent
Axxelent is a company based in Chennai (India) founded in 2007. It operates as a B2B. Axxelent operates in a competitive market with competitors including Pharmaron, Lonza, Pfizer, Boehringer Ingelheim and LabConnect, among others.
- Headquarter Chennai, India
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website axxelent.com
- Social LinkedIn Facebook
Associated legal entities of Axxelent
Axxelent is associated with 2 registered companies on The Company Check. Each company page carries the filings, financials, charges and directors of that entity.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2022) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Axxelent Pharmaceuticals Private Limited CIN U24304TN2019PTC131656 | Strike Off | 18 Sep 2019 | Chennai, Tamil Nadu | – | – | 2 | View details |
| Axxelent Pharma Science Private Limited CIN U24110TN2019PTC131943 | Active | 07 Oct 2019 | Chennai, Tamil Nadu | ₹105 Cr | 330 | 11 | View details |
Board of directors of Axxelent
The boards of the 2 registered companies of Axxelent currently have 8 directors; the longest-serving is Shankarlal Devendra, appointed in 2019. 6 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Shankarlal Devendra DIN 00050440 | Director | 18 Sep 2019 | 7 yrs | Axxelent Pharmaceuticals Private Limited |
| Sampath Kumar Devarajan DIN 08565891 | Director | 07 Oct 2019 | 7 yrs | Axxelent Pharma Science Private Limited, Axxelent Pharmaceuticals Private Limited |
| Sreenivasa Reddy Bhimanatham DIN 08955389 | Whole-time director | 04 Dec 2020 | 5 yrs 10 mo | Axxelent Pharma Science Private Limited |
| Jitesh Devendra DIN 06469234 | Managing Director | 04 Dec 2020 | 5 yrs 10 mo | Axxelent Pharma Science Private Limited |
| Hariharan Subramanian DIN 05297969 | Director | 01 Jul 2021 | 5 yrs 3 mo | Axxelent Pharma Science Private Limited |
| Chaitanya Devandra DIN 06776403 | Whole-time director | 22 Apr 2022 | 4 yrs 5 mo | Axxelent Pharma Science Private Limited |
| Kamlesh Phulwani DIN 03100409 | Nominee Director | 10 Apr 2023 | 3 yrs 6 mo | Axxelent Pharma Science Private Limited |
| Swaminathan Ramesh DIN 08449996 | CFO | 06 Sep 2025 | 1 yr 1 mo | Axxelent Pharma Science Private Limited |
Financials of Axxelent
Figures of Axxelent Pharma Science Private Limited, the primary company behind Axxelent, for FY 2026. Revenue was ₹105 Cr (+63% year on year). Net profit was ₹7.80 Cr (7% margin). EBITDA was ₹41.80 Cr (40% margin). Revenue has grown at a compounded annual rate of +149% over three years and +158% over five years.
- ₹105 CrRevenue · FY 2026 · +63% YoY
- ₹7.80 CrNet profit · 7% margin
- ₹41.80 CrEBITDA · 40% margin
- ₹61.67 CrPaid-up capital
- 330Employees (provident fund records)
- +149%Revenue CAGR, 3 years
- +158%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Axxelent Pharma Science Private Limited are on its company page.
Detailed financial statements for Axxelent
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Competitors of Axxelent
Axxelent operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Pharmaron, Lonza, Pfizer, Boehringer Ingelheim and LabConnect, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| pharmaron.com | 2003 | Beijing, China | $320M | 476 | Drug discovery and development services for small molecules are provided. | |
| lonza.com | 1897 | Basel, Switzerland | $100,000 | 14,500 | CDMO services for pharma, biotech, and specialty ingredients are provided. | |
| pfizer.com | 1849 | New York, United States | $8M | – | Pharmaceutical products for treating multiple diseases are provided. | |
| boehringer-ingelheim.com | 1885 | – | – | 31 | Generic drugs and clinical research services are provided globally. | |
| labconnect.com | 2002 | Johnson, United States | $28.5M | – | Laboratory testing, clinical trial research, and biopharma services are provided. | |
| ainos.com | 1986 | San Diego, United States | – | 43 | Novel point-of-care testing and low-dose interferon therapeutics are developed. | |
| biomatter.ai | 2018 | Vilnius, Lithuania | $7.73M | – | Provider of synthetic biology and AI-based technology for generative protein design | |
| betadrugslimited.com | 2005 | Panchkula, India | – | 637 | Developer of therapeutics for oncology and dermatology | |
| evergreentgn.com | 2019 | Jersey, United States | $75.91M | – | Radiopharmaceutical manufacturing and regulatory services are provided. |
Detailed competitors of Axxelent
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Axxelent
The website of Axxelent (axxelent.com) receives about 1.6K visits a month.
- Monthly visits1.6K
▼ 10.7% vs previous month
Websites whose visitors overlap most with Axxelent. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| nmsworks.co.in | 100% | 1.3K | #11,210,005 | View details | |
| xyma.in | 93% | 1.6K | – | View details |
Latest news on Axxelent
Complete news archive for Axxelent
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to Axxelent
10 companies that operate in the same segment as Axxelent (Pharmaceuticals & Distribution), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Pharmaceutical products are manufactured and marketed worldwide. | 1891 | Kenilworth, Warwickshire, United Kingdom | – | USD 64.93 B | 781 | |
Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed. | 2014 | New York, New York, United States | USD 1.3 B | USD 8.26 M | 750 | |
Developer of pharmaceutical products for treating multiple diseases | 1980 | Thousand Oaks, California, United States | – | USD 33.23 B | 28,000 | |
Biopharmaceutical research and drug development are conducted globally by AbbVie. | 2012 | Chicago, Illinois, United States | – | USD 61.16 B | 55,000 | |
Traditional pharmaceutical medicines are developed for multiple health fields. | 1876 | United States | – | USD 65.18 B | 47,000 | |
Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others | 1987 | Foster City, California, United States | – | USD 29.45 B | 17,600 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
Treatments for anemia and fibrosis by exploiting connective tissue growth factor (CTGF) and hypoxia-inducible factor (HIF) biology. | 1993 | San Francisco, California, United States | USD 215.5 M | USD 29.62 M | 225 | |
Developer of medical devices, generic pharmaceuticals, and nutrition products | 1888 | Libertyville, Illinois, United States | – | USD 44.33 B | 3,710 | |
Medicines and health products are retailed through pharmacy outlets. | 2006 | Hyderabad, Telangana, India | USD 268.78 M | USD 734.57 M | 25,010 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Axxelent
Axxelent was founded in 2007.
Axxelent is headquartered in Chennai, India. It is registered at Chennai, Tamil Nadu, India.
Axxelent, established in 2007, excels in providing healthcare solutions, producing pharmaceutical products, manufacturing services, and cdmo operations. Provides CDMO services focused on pharmaceutical formulations and regulatory support. Committed to advancing standards, it focuses on innovation, efficiency, and delivering value to clients worldwide.
Axxelent is associated with 2 legal entities: Axxelent Pharma Science Private Limited, Axxelent Pharmaceuticals Private Limited.
The legal entities of Axxelent currently have 12 directors, including Sreenivasa Reddy Bhimanatham, Swaminathan Ramesh, Sampath Kumar Devarajan and others.